trending Market Intelligence /marketintelligence/en/news-insights/trending/wlpjsu3tlywmlkmdhevfka2 content esgSubNav
In This List

Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

The U.S. Food and Drug Administration cleared Cutera Inc.'s nonsurgical body sculpting system truSculpt 3D for lipolysis, or the breakdown of fat.

The device previously has FDA clearance for the reduction of fat without surgery.

Brisbane, Calif.-based Cutera is a medical device company that designs, develops, manufactures, markets and services laser and other energy-based aesthetics systems worldwide.